Swing Therapeutics leveraged Medrio ePRO in a proof-of-concept for a decentralized hybrid study. Electronic Patient-Reported Outcomes (ePRO) technology was used to assess the results of varying digital therapies and the feasibility of conducting a largely virtual clinical study in a fibromyalgia population.
Swing Therapeutics Achieved 97% Patient Compliance with ePRO
- Success Story
- DCT, eCOA / ePRO
Subscribe to our mailing list
Sign up to have our latest insights delivered to your inbox.
